2021
DOI: 10.5664/jcsm.8986
|View full text |Cite
|
Sign up to set email alerts
|

Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline

Abstract: Introduction: This guideline establishes clinical practice recommendations for the use of behavioral and psychological treatments for chronic insomnia disorder in adults. Methods: The American Academy of Sleep Medicine (AASM) commissioned a task force of experts in sleep medicine and sleep psychology to develop recommendations and assign strengths based on a systematic review of the literature and an assessment of the evidence using Grading of Recommendations Assessment, Development and Evaluation (GRADE) meth… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

7
233
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 359 publications
(288 citation statements)
references
References 9 publications
7
233
0
2
Order By: Relevance
“… 7 , 8 Other than the different treatments required for distinctive comorbidities, effective treatments for insomnia generally are the same across “primary” or “secondary” insomnia. 1 , 2 , 9 , 10 It is important to note, however, that for some of the more recent insomnia treatments (eg, dual orexin receptor antagonists [DORAs]), less is known about their effectiveness in patients with insomnia and comorbidities as these newer agents are relatively new and studies of those that have become commercially available have not yet been conducted to evaluate their efficacy specifically in insomnia patients with co-occurring disorders.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations
“… 7 , 8 Other than the different treatments required for distinctive comorbidities, effective treatments for insomnia generally are the same across “primary” or “secondary” insomnia. 1 , 2 , 9 , 10 It is important to note, however, that for some of the more recent insomnia treatments (eg, dual orexin receptor antagonists [DORAs]), less is known about their effectiveness in patients with insomnia and comorbidities as these newer agents are relatively new and studies of those that have become commercially available have not yet been conducted to evaluate their efficacy specifically in insomnia patients with co-occurring disorders.…”
Section: Introductionmentioning
confidence: 99%
“…As regards behavioral and psychological treatments for chronic insomnia, clinical practice guidelines from the AASM and the American College of Physicians (ACP) both indicate that standard-of-care should be to at least provide cognitive behavioral therapies for insomnia (CBT-I) as first-line nonpharmacologic treatment. 9 , 67 Indeed, CBT-I is the only nonpharmacologic treatment for chronic insomnia that has received a strong recommendation for use by the AASM. 9 This is likely due in part by the numerous meta-analyses demonstrating robust clinical improvements across numerous sleep-related outcomes using individual, group, internet-based, and self-help CBT-I.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…At present non-drug therapy and drug therapy are usually used to treat chronic insomnia. Many patients with chronic insomnia have to take sedative hypnotic drugs for a long time to maintain sleep, and long-term use of drugs will bring a series of side effects and adverse reactions [4]. Therefore, it is necessary to find new effective non-drug treatments to improve the quality of sleep of chronic patients.…”
mentioning
confidence: 99%